Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
5
×
life sciences
national blog main
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san francisco blog main
san francisco top stories
5
×
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
detroit blog main
detroit top stories
eli lilly
indiana blog main
indiana top stories
national
national top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
cancer
cancer immunotherapy
deals
johnson & johnson
medical device
migraine
startups
abbvie
aduro biotech
agenus
alzheimer's disease
What
companies
5
×
drug
5
×
bio
roundup
approval
fda
migraine
nash
new
news
price
therapies
year
activity
alzheimer’s
approved
arguments
big
biogen’s
biopharmaceutical
biotech
class
commercialized
competitors
convo
days
decades
different
digital
disease
dog
drugs
earlier
epidemic
fail
failures
fatty
firm
frenzied
gene
Language
unset
Current search:
biotech
×
companies
×
drug
×
" san francisco top stories "
×
@xconomy.com
4 years ago
Pfizer Spinout SpringWorks, Migraine Drug Firm Satsuma Prep IPOs
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More